Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. The company offers aurora and northern lights systems delivers cell analysis; aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; enhanced small particle detection; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. It serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Cytek Biosciences Inc.

Cytek Biosciences, Inc. (CTKB) has disclosed a new risk, in the Capital Markets category. The analyst notes that Cytek Biosciences, Inc. faces heig...

Cytek Biosciences Faces Rising Risk From U.S.–China Trade Tensions and Tariff Pressures

Cytek Biosciences, Inc. (($CTKB)) has held its Q1 earnings call. Read on for the main highlights of the call. Cytek Biosciences’ latest earnings ca...

Market Cap	$639.32M	P/E Ratio	N/A
52W High	$6.18	52W Low	$2.90
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	-100.0%	52W Position	36.3%
Overall Score	53	Value Score	60
Quality Score	55	Technical Score	45

EPS Current Est	$-0.22	EPS Next Est	$0.01
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CTKB	$4.09	-5.54%	912.42K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CTKB	$4.09	-5.5%	912.42K
3
4
5
6

CTKB

CTKB

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Cytek Biosciences Inc. Data in Excel

Get Cytek Biosciences Inc. Data in Excel